Cargando…

Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease?

Detalles Bibliográficos
Autor principal:	Muller, Claude P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127950/ https://www.ncbi.nlm.nih.gov/pubmed/34027513 http://dx.doi.org/10.1016/j.lanepe.2021.100118

Ejemplares similares

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
por: Oliu-Barton, Miquel, et al.
Publicado: (2022)

Integrating Biodiversity Infrastructure into Pathogen Discovery and Mitigation of Emerging Infectious Diseases
por: Cook, Joseph A, et al.
Publicado: (2020)

Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2022)

Can Robots Improve Testing Capacity for SARS-CoV-2?
por: Cresswell, Kathrin, et al.
Publicado: (2020)

Therapeutic Potential of Inducible Endogenous Cytoprotective Heme Oxygenase-1 in Mitigating SARS-CoV-2 Infection and Associated Inflammation
por: Dhawan, Subhash
Publicado: (2022)

SARS-CoV-2 vaccine development, access, and equity
por: Kim, Jerome H.
Publicado: (2020)

EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
por: Bijlsma, Johannes WJ
Publicado: (2021)

SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health
por: Sarkar, Mohammad Abdullah, et al.
Publicado: (2021)

COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache
por: Martelletti, Paolo
Publicado: (2023)

Can Disinfection Robots Reduce the Risk of Transmission of SARS-CoV-2 in Health Care and Educational Settings?
por: Cresswell, Kathrin, et al.
Publicado: (2020)

Implementing and Maintaining a SARS-CoV-2 Exposure Notification Application for Mobile Phones: The Finnish Experience
por: Pihlajamäki, Mika, et al.
Publicado: (2023)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2022)

Marketing SARS-CoV-2 Vaccines: an Opportunity to Test a Nobel Prize–Winning Theory
por: Verma, Amol A., et al.
Publicado: (2021)

In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease
por: Epelbaum, Oleg, et al.
Publicado: (2020)

SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view
por: Spada, F., et al.
Publicado: (2020)

Epidemiological profiles of SARS-CoV and SARS-Cov-2 in Singapore and its promising containment strategies
por: Chaturvedi, Rini, et al.
Publicado: (2021)

COVID-19 vaccine strategies must focus on severe disease and global equity
por: McIntyre, Peter B, et al.
Publicado: (2022)

Mitigation of COVID-19 clusters in Malaysia
por: Danial, Monica, et al.
Publicado: (2020)

Can sequential aerosol technique be used against riverine tsetse?
por: De Deken, Reginald, et al.
Publicado: (2018)

The SARS-CoV-2 crisis and its impact on neglected tropical diseases: Threat or opportunity?
por: Chaumont, Claire, et al.
Publicado: (2020)

Integrated healthcare approach can curb the increasing cases of cryptococcosis in Africa
por: Ibe, Chibuike, et al.
Publicado: (2022)

Influencing factors of SARS-Cov2 spread in Africa
por: Admou, Brahim, et al.
Publicado: (2020)

SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021)

Hardwiring antimicrobial resistance mitigation into global policy
por: Thornber, Kelly, et al.
Publicado: (2022)

The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread
por: Nachega, Jean, et al.
Publicado: (2020)

A therapeutic preconceptional vaccine against Chagas disease: A novel indication that could reduce congenital transmission and accelerate vaccine development
por: Dumonteil, Eric, et al.
Publicado: (2019)

Human-Animal Interaction and the Emergence of SARS-CoV-2
por: Hassani, Asma, et al.
Publicado: (2020)

Schrödinger’s Worker: Are They Positive or Negative for SARS-CoV-2?
por: Meloni, Federico, et al.
Publicado: (2020)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Immunosuppression: Cause for Failures of Vaccines against African Trypanosomiases
por: Tabel, Henry, et al.
Publicado: (2013)

Reducing Aerosol Transmission of SARS-CoV-2 in Craniomaxillofacial Osteosynthesis
por: Arakeri, Gururaj, et al.
Publicado: (2020)

Targeting neuropilins as a viable SARS‐CoV‐2 treatment
por: Sarabipour, Sarvenaz, et al.
Publicado: (2021)

Global variation in sequencing impedes SARS-CoV-2 surveillance
por: Crawford, Dana C., et al.
Publicado: (2021)

Recommendations for return to sport during the SARS-CoV-2 pandemic
por: Löllgen, Herbert, et al.
Publicado: (2020)

Can early measles vaccination control both measles and respiratory syncytial virus infections?
por: Do, Lien Anh Ha, et al.
Publicado: (2022)

Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks
por: Espeland, Eric M., et al.
Publicado: (2018)

The urgent need for more basic research on SARS-Cov2 infection and vaccines in assessing potential psychoneurological effects using maternal immune activation (MIA) and other preclinical modeling
por: Murphy, William J.
Publicado: (2021)

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020)

Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection
por: Thapa, Bibechan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f6d3193ktf2dflh7dr2tg9s8up